FDA Drug Application (203816) for FLUDEOXYGLUCOSE F18 by BRIGHAM WOMENS

Back to FDA Applications sponsored by BRIGHAM WOMENS

Application Number203816
Product Number001
FormINJECTABLE;INTRAVENOUS
Dosage20-300mCi/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameFLUDEOXYGLUCOSE F18
Active IngredientFLUDEOXYGLUCOSE F-18



Back to FDA Applications sponsored by BRIGHAM WOMENS